doi: 10.1002/1097-0142(19880115)61:2<376::aid-cncr2820610229>3.0.co;2-y.
An experience with an implanted port system in 66 children with cancer
Affiliations
- PMID: 3334972
- DOI: 10.1002/1097-0142(19880115)61:2<376::aid-cncr2820610229>3.0.co;2-y
Item in Clipboard
An experience with an implanted port system in 66 children with cancer
Cancer.
.
Abstract
Totally implanted port catheter systems have a lower incidence of infection and are more easily used in home care that external catheters in adult cancer patients. Experience with this method in children has been limited. During the past 2 years, we have implanted 71 ports in 66 children with cancer. Our experience demonstrates an infection rate (0.15 episodes of bacteremia per 100 patient days) slightly lower than that reported for children with Broviac or Hickman catheters, but not as low as that seen in adults with implanted systems. Patients and families have been extremely satisfied with the devices. Our experience supports further use of implanted systems in children with cancer.
Similar articles
-
A totally implanted venous access system used in pediatric patients with cancer.J Clin Oncol. 1987 Jan;5(1):137-40. doi: 10.1200/JCO.1987.5.1.137. J Clin Oncol. 1987. PMID: 3806156
-
Infection rates of Broviac-Hickman catheters and implantable venous devices.Am J Dis Child. 1988 May;142(5):536-40. doi: 10.1001/archpedi.1988.02150050074036. Am J Dis Child. 1988. PMID: 3358396
-
A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients.J Clin Oncol. 1989 Feb;7(2):214-22. doi: 10.1200/JCO.1989.7.2.214. J Clin Oncol. 1989. PMID: 2915237 Clinical Trial.
-
[Use of the Broviac/Hickman catheter in pediatric oncology].Klin Padiatr. 1988 Jan-Feb;200(1):49-56. doi: 10.1055/s-2008-1033685. Klin Padiatr. 1988. PMID: 3285088 Review. German.
-
Port-A-Cath infections in children with cancer.Eur J Cancer. 2004 Nov;40(16):2452-8. doi: 10.1016/j.ejca.2004.07.017. Eur J Cancer. 2004. PMID: 15519519 Review.
Cited by
-
Implantable versus cuffed external central venous catheters for the management of children and adolescents with acute lymphoblastic leukaemia.Pediatr Surg Int. 2012 Dec;28(12):1195-9. doi: 10.1007/s00383-012-3213-4. Epub 2012 Nov 23. Pediatr Surg Int. 2012. PMID: 23178960
-
Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique.Antimicrob Agents Chemother. 2001 May;45(5):1565-7. doi: 10.1128/AAC.45.5.1565-1567.2001. Antimicrob Agents Chemother. 2001. PMID: 11302830 Free PMC article.
-
Morbidity using subcutaneous ports and efficacy of vancomycin flushing in cancer.Arch Dis Child. 1995 Apr;72(4):325-9. doi: 10.1136/adc.72.4.325. Arch Dis Child. 1995. PMID: 7763065 Free PMC article.
-
Central venous catheter tip position and malfunction in a paediatric oncology unit.Pediatr Surg Int. 1996 Mar;11(2-3):159-63. doi: 10.1007/BF00183753. Epub 2013 Sep 21. Pediatr Surg Int. 1996. PMID: 24057544
-
Antimicrobial therapy in palliative care: an overview.Support Care Cancer. 2018 May;26(5):1361-1367. doi: 10.1007/s00520-018-4090-8. Epub 2018 Feb 12. Support Care Cancer. 2018. PMID: 29435712 Review.
MeSH terms
LinkOut - more resources
Medical
Miscellaneous